Equities
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
PFE:NYQ since
announced
Transaction
value
Trillium Therapeutics IncDeal completed23 Aug 202123 Aug 2021Deal completed11.39%2.21bn
Glaxosmithkline Plc- Consumer UnitAnnounced03 Jun 202103 Jun 2021Announced39.91%--
Amplyx Pharmaceuticals IncDeal completed28 Apr 202128 Apr 2021Deal completed41.14%--
Data delayed at least 15 minutes, as of Dec 03 2021 21:10 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.